Emcure Pharmaceuticals Limited — Important, 19-06-2025: Updates

Emcure Pharmaceuticals has announced a board meeting to consider requests from multiple entities and individuals currently classified as Promoter and Promoter Group to be re-classified as Public category shareholders. All applicants confirm they hold no equity shares, have no control or special rights in the company, and are not involved in the company's management or operations. These re-classifications, once approved, will reduce the promoter group's size and may improve stock liquidity by increasing the public float. No financial impact or regulatory issues were noted in the requests.